← FDA DRUG APPROVALS

FDA ANDA · ANDA090769

CLENZ-LYTE

Sponsor: PADDOCK LLC

APPLICATION
ANDA090769
TYPE
ANDA
ORIGINAL APPROVAL
2010-06-07
LATEST ACTION
2010-06-07
ROUTE
ORAL
DOSAGE FORM
FOR SOLUTION
MARKETING STATUS
Discontinued

Products

CLENZ-LYTEDiscontinued
POLYETHYLENE GLYCOL 3350 236GM/BOT, POTASSIUM CHLORIDE 2.97GM/BOT, SODIUM BICARBONATE 6.74GM/BOT, SODIUM CHLORIDE 5.86GM/BOT, SODIUM SULFATE 22.74GM/BOT · FOR SOLUTION · ORAL

Approval history

2010-06-07OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →